Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026)
Cronos (CRON) recorded quarterly Income from Non-Controlling Interests of $1.1 million in Q1 2026, down 17.74% quarter-over-quarter from $1.3 million in Q4 2025, and down 24.46% on a YoY basis from $1.4 million in Q1 2025.
Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Cronos' Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 24.46% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.3 million (up 468.74% YoY), while the FY2025 annual figure was $6.5 million, up 305.23% from the prior year.
- Income from Non-Controlling Interests was $1.1 million for Q1 2026 at Cronos, down from $1.3 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2024.
- Historically, Income from Non-Controlling Interests has averaged $166764.7 across 5 years, with a median of -$87000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests slumped 1001.73% in 2024, then soared 2018.97% in 2025.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$16000.0 in 2022, then sank by 981.25% to -$173000.0 in 2023, then plunged by 1001.73% to -$1.9 million in 2024, then surged by 169.52% to $1.3 million in 2025, then retreated by 17.74% to $1.1 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Cronos | 1.06 Bn | 284.85 Mn | 19.15 Mn | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | -243,000.00 |
| Dec 31, 2023 | -173,000.00 |
| Sep 30, 2023 | -128,000.00 |
| Jun 30, 2023 | -87,000.00 |
| Mar 31, 2023 | -88,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Jun 30, 2022 | -117,000.00 |
| Mar 31, 2022 | -261,000.00 |
| Dec 31, 2021 | 62,000.00 |
| Sep 30, 2021 | -250,000.00 |
| Jun 30, 2021 | -394,000.00 |